PGX-HIV StripAssay®

The PGX-HIV StripAssay® identifies allelic variants which play a large role in the success of Highly Active Retroviral Therapy (HAART). Through identification of of these important genetic variations, treatment for patients can be tailored for maximum effectiveness.

PGX-HIV StripAssay® Brochure

  • Kits are based on reverse-hybridization of biotinylated PCR products.
  • Minimal equipment required (thermal cycler, shaking water bath).
  • Technology combines probes for mutations and controls in a parallel array of allele-specific oligonucleotides.
  • Functions using immobilized oligos on a teststrip.
  • Strips show mutations by enzymatic color reaction visible to the naked eye.
  • Proprietary software package (Evaluator™) that aids in data interpretation, storage, and archiving.

PGX HIV Chart

Genetic Variants Detected

PGX-HIV StripAssay® Catalog 4-710

MDR1 (3435 C>T)

CYP2D6 (*3/*4/*6)

CCR5 (32 bp deletion)

 

For Research Use Only [RUO]. Not for use in diagnostic procedures.